Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method. 1984

J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima

We measured procainamide and its active metabolite, N-acetylprocainamide (NAPA), in 80 sera from 37 patients by a new fluorimmunoassay procedure and an established "high-performance" liquid-chromatographic method. Additive and proportional differences between the methods were 0.07 mg/L and 9%, respectively, for procainamide and 0.62 mg/L and 16% for NAPA. Between-day CVs by the chromatographic and immunoassay methods, respectively, were 3.9% and 2.2% for procainamide at a concentration of 6 mg/L, and 5.1% and 1.2% for NAPA (14 mg/L). We applied a modification of the fluoroimmunoassay for determination of procainamide concentrations, using sera obtained during a pharmacokinetic study, and demonstrated excellent agreement with the chromatographic method.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000120 Acecainide A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure. Acetylprocainamide,Acecainide Hydrochloride,Acecainide Monohydrochloride,N-Acetylprocainamide,Hydrochloride, Acecainide,Monohydrochloride, Acecainide,N Acetylprocainamide
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
June 1983, Therapeutic drug monitoring,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
June 1988, Yao xue xue bao = Acta pharmaceutica Sinica,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
June 1978, Journal of pharmaceutical sciences,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
January 1991, Biomedical chromatography : BMC,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
February 1986, Research communications in chemical pathology and pharmacology,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
April 1979, Journal of pharmaceutical sciences,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
December 1981, Circulation,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
January 1982, Journal of analytical toxicology,
J J MacKichan, and J D Coyle, and B J Shields, and H Boudoulas, and J J Lima
January 1982, Journal of immunoassay,
Copied contents to your clipboard!